{"name":"Intrexon Corporation","permalink":"intrexon-corporation","crunchbase_url":"http://www.crunchbase.com/company/intrexon-corporation","homepage_url":"http://www.dna.com","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"swright@intrexon.com","phone_number":"540-961-072","description":"Life sciences company","created_at":"Thu Jun 04 01:32:18 UTC 2009","updated_at":"Tue Oct 25 02:14:38 UTC 2011","overview":"<p>Intrexon is a privately held life sciences company headquartered at the Virginia Tech Corporate Research Center in Blacksburg, Virginia, with additional R&amp;D operations in Valley Forge, Pennsylvania. The company is focused on the research and development of biotherapeutic control systems that minimize toxicity while enhancing clinical outcomes. More information is available at www.DNA.com.</p>","image":{"available_sizes":[[[120,29],"assets/images/resized/0004/6575/46575v1-max-150x150.jpg"],[[120,29],"assets/images/resized/0004/6575/46575v1-max-250x250.jpg"],[[120,29],"assets/images/resized/0004/6575/46575v1-max-450x450.jpg"]],"attribution":null},"products":[],"relationships":[{"is_past":false,"title":"CEO and Chairman","person":{"first_name":"Randal","last_name":"J. Kirk","permalink":"randal-j-kirk","image":null}},{"is_past":false,"title":"Chief Operating Officer","person":{"first_name":"Marcelo","last_name":"Quiroga","permalink":"marcelo-quiroga","image":null}},{"is_past":false,"title":"Founder & Chief Science Officer","person":{"first_name":"Thomas","last_name":"D. Reed","permalink":"thomas-d-reed","image":null}},{"is_past":false,"title":"CFO","person":{"first_name":"Rick","last_name":"Sterling","permalink":"rick-sterling","image":null}}],"competitions":[],"providerships":[],"total_money_raised":"$187M","funding_rounds":[{"round_code":"c","source_url":"http://www.dna.com/news/20080507.aspx","source_description":"Intrexon Corporation Secures $25 Million Series C-2 Investment.","raised_amount":25000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":5,"funded_day":7,"investments":[{"company":null,"financial_org":{"name":"Third Security","permalink":"third-security","image":{"available_sizes":[[[150,35],"assets/images/resized/0004/6579/46579v1-max-150x150.png"],[[250,59],"assets/images/resized/0004/6579/46579v1-max-250x250.png"],[[324,77],"assets/images/resized/0004/6579/46579v1-max-450x450.png"]],"attribution":null}},"person":null}]},{"round_code":"c","source_url":"http://onbiovc.com/intrexon-corp-series-c-10m/","source_description":"Intrexon Corp.: Series C $10M","raised_amount":10000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":7,"funded_day":7,"investments":[{"company":null,"financial_org":{"name":"New River Management","permalink":"new-river-management","image":{"available_sizes":[[[150,35],"assets/images/resized/0007/2973/72973v1-max-150x150.png"],[[250,59],"assets/images/resized/0007/2973/72973v1-max-250x250.png"],[[324,77],"assets/images/resized/0007/2973/72973v1-max-450x450.png"]],"attribution":null}},"person":null}]},{"round_code":"c","source_url":"http://www.sec.gov/Archives/edgar/data/1356090/000135609010000001/xslFormDX01/primary_doc.xml","source_description":"SEC D","raised_amount":25000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":1,"funded_day":5,"investments":[]},{"round_code":"c","source_url":"http://venturebeat.com/2007/05/16/intrexon-picks-up-25m-for-gene-therapy/","source_description":"Intrexon picks up $25M for gene therapy","raised_amount":25000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":5,"funded_day":16,"investments":[{"company":null,"financial_org":{"name":"Third Security","permalink":"third-security","image":{"available_sizes":[[[150,35],"assets/images/resized/0004/6579/46579v1-max-150x150.png"],[[250,59],"assets/images/resized/0004/6579/46579v1-max-250x250.png"],[[324,77],"assets/images/resized/0004/6579/46579v1-max-450x450.png"]],"attribution":null}},"person":null}]},{"round_code":"unattributed","source_url":"http://www.allbusiness.com/banking-finance/financial-markets-investing/5455564-1.html","source_description":"Intrexon Corporation Raises $1 Million For Advancing its Subcellular Tools.","raised_amount":1000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":3,"funded_day":1,"investments":[{"company":null,"financial_org":{"name":"NewVa Capital Partners","permalink":"newva-capital-partners","image":{"available_sizes":[[[150,27],"assets/images/resized/0008/9392/89392v1-max-150x150.jpg"],[[250,45],"assets/images/resized/0008/9392/89392v1-max-250x250.jpg"],[[391,71],"assets/images/resized/0008/9392/89392v1-max-450x450.jpg"]],"attribution":null}},"person":null}]},{"round_code":"b","source_url":"","source_description":"Cap Funding Report","raised_amount":500000,"raised_currency_code":"USD","funded_year":2005,"funded_month":5,"funded_day":17,"investments":[{"company":null,"financial_org":{"name":"Third Security","permalink":"third-security","image":{"available_sizes":[[[150,35],"assets/images/resized/0004/6579/46579v1-max-150x150.png"],[[250,59],"assets/images/resized/0004/6579/46579v1-max-250x250.png"],[[324,77],"assets/images/resized/0004/6579/46579v1-max-450x450.png"]],"attribution":null}},"person":null}]},{"round_code":"e","source_url":"http://www.fiercebiotech.com/story/biotech-billionaire-raises-100m-synthetic-biology-venture-intrexon/2011-05-31?utm_medium=rss&utm_source=rss","source_description":"Biotech billionaire raises $100M for synthetic biology venture Intrexon","raised_amount":100000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":5,"funded_day":31,"investments":[{"company":null,"financial_org":{"name":"Third Security","permalink":"third-security","image":{"available_sizes":[[[150,35],"assets/images/resized/0004/6579/46579v1-max-150x150.png"],[[250,59],"assets/images/resized/0004/6579/46579v1-max-250x250.png"],[[324,77],"assets/images/resized/0004/6579/46579v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"New River Management","permalink":"new-river-management","image":{"available_sizes":[[[150,35],"assets/images/resized/0007/2973/72973v1-max-150x150.png"],[[250,59],"assets/images/resized/0007/2973/72973v1-max-250x250.png"],[[324,77],"assets/images/resized/0007/2973/72973v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"NewVa Capital Partners","permalink":"newva-capital-partners","image":{"available_sizes":[[[150,27],"assets/images/resized/0008/9392/89392v1-max-150x150.jpg"],[[250,45],"assets/images/resized/0008/9392/89392v1-max-250x250.jpg"],[[391,71],"assets/images/resized/0008/9392/89392v1-max-450x450.jpg"]],"attribution":null}},"person":null}]}],"investments":[],"acquisition":null,"acquisitions":[{"price_amount":null,"price_currency_code":"USD","term_code":null,"source_url":"http://www.dna.com/20111024","source_description":"Intrexon Acquires Immunologix, Inc.","acquired_year":2011,"acquired_month":10,"acquired_day":24,"company":{"name":"Immunologix","permalink":"immunologix","image":{"available_sizes":[[[150,37],"assets/images/resized/0009/4660/94660v1-max-150x150.jpg"],[[250,61],"assets/images/resized/0009/4660/94660v1-max-250x250.jpg"],[[259,64],"assets/images/resized/0009/4660/94660v1-max-450x450.jpg"]],"attribution":null}}}],"offices":[],"milestones":[],"ipo":null,"video_embeds":[],"screenshots":[{"available_sizes":[[[150,80],"assets/images/resized/0004/6574/46574v1-max-150x150.jpg"],[[250,134],"assets/images/resized/0004/6574/46574v1-max-250x250.jpg"],[[450,242],"assets/images/resized/0004/6574/46574v1-max-450x450.jpg"]],"attribution":null}],"external_links":[]}